Let's get one thing straight: the stock options your hot new AI startup just offered you are probably worth 30% less than the number on the offer letter. It’s not a bug. It’s a feature of the most cynical, and frankly brilliant, financial engineering I’ve seen since the dot-com bust.
The tech press is calling it "dual-pricing" or "strategic-investor discounts." It sounds sophisticated. It sounds intentional. It’s a shell game. Startups, desperate for the computing power to train their massive models, are paying for it with their own stock. But they aren't selling that stock to Nvidia, Google, or Microsoft at the same price they’re selling it to Andreessen Horowitz.
No, the VCs writing cash checks pay one price—the headline valuation you see on TechCrunch. But the tech giants providing the silicon get a steep discount. The same preferred shares, two different price tags. And nobody wants to talk about who gets screwed in the middle.
The Official Story vs. The Grimy Reality
The pitch I keep hearing in boardrooms and over lukewarm coffee goes like this: "This isn't a discount. It's a strategic partnership. We're getting more than just GPUs; we're getting access to their ecosystem, their enterprise clients, their engineering support." It’s a tidy narrative. It almost sounds reasonable.
It's also mostly nonsense.
The reality is that building a foundational model in 2026 is less about code and more about capital. You need a colossal amount of computing power, and that costs a fortune in cold, hard cash. A startup might burn through $100 million in cloud compute and hardware before they even have a product that can reliably tell you the capital of Nebraska. Most VCs, even with their billion-dollar funds, blanch at writing checks that go straight into Jensen Huang's pocket. They want their money to hire engineers, not just rent servers.
So, the new playbook is to carve out a separate deal. A startup raises, say, $200 million in cash from VCs at a $2 billion post-money valuation. That’s the number they shout from the rooftops. But quietly, in a side letter, they also cut a deal with a cloud provider for $100 million in compute credits. In exchange, the cloud provider gets $100 million worth of equity… but valued at a 30% discount. They’re effectively buying shares at a $1.4 billion valuation.
The startup gets its compute. The VCs get to mark their investment at the higher $2 billion figure. The cloud provider gets a cheap entry point into a potential rocket ship. Everyone wins, right?
Wrong. This creates a phantom valuation. The company isn’t truly worth $2 billion if it’s simultaneously selling large chunks of itself for much less.
How Do AI Companies Actually Make Money With This Model?
For now, they don't. That's the dirty secret. This isn't a revenue model; it's a survival mechanism. The primary goal of many of these AI startups isn't to find product-market fit or generate cash flow. It's to survive long enough to do the next, bigger fundraise at an even more ludicrous valuation.
Follow the money. Who benefits the most here?
- The Chipmakers and Cloud Providers: Nvidia, AWS, Google Cloud, and Microsoft Azure are the new kingmakers. They can turn their primary product—compute—into a venture portfolio. They lock in a major customer and get a lottery ticket on their success. It's a brilliant move, turning a cost center for startups into an asset for themselves. It also fuels Nvidia's seemingly unstoppable growth, creating a powerful, self-reinforcing loop.
- The Venture Capitalists: VCs get to maintain the illusion of high-growth, high-valuation portfolios. A fund's performance is judged by its "marks"—the on-paper value of its investments. By anchoring the valuation to the cash price, they can show their own investors (the LPs) fantastic returns, even if the underlying company's value is softer than a week-old croissant. This helps them raise their next, even larger, fund.
- The Founders: Founders get the compute they desperately need without giving up as much of the company as they would in a pure cash-for-compute transaction. They also get to boast about their shiny new unicorn valuation, which helps with press and, most importantly, recruiting.
But this house of cards is built on a shaky foundation. The actual, blended valuation of the company is somewhere between the high cash price and the low compute price. It obfuscates the true health of the business. It’s financial doping.



